We have a track record of over 20 years of success in our vaccine manufacturing. Our vaccine manufacturing facility can prepare vaccine antigen for human or non-clinical studies.
Our past projects include recombinant proteins, whole cell vaccines, viral vaccines, probiotics, and synthetic molecules for preclinical, Phase I to III human clinical trials, and commercial veterinary products for clients both within Australia and in the U.S., New Zealand, and Asia.
If you need to make a custom bacterial vaccine, we have the expertise and adaptability you need.
cGMP Vaccine Manufacturing
AcuraBio offers a range of cGMP production options from live, attenuated vaccines to recombinant protein production, including:
- Dedicated manufacturing and biosafety containment areas including BSL-2 labs
- Specialty services in formalin killing and removal
- Production of live or killed bacterial vaccines
- Recombinant vaccines
- Antigen capture and stabilization
- Flask or fermentation for recombinant vaccines
- Documentation and support services
Our scientists and staff work with you to design a successful campaign using a variety of approaches:
- Live, attenuated vaccines
- Inactivated vaccines
- Subunit vaccines
- Toxoid vaccines
- Conjugate vaccines
- Recombinant vaccines
A dedicated project manager will assist you in understanding the best approach that fits your needs based on targeted information about the microbe, pathway to infection, immune system response, and global conditions that may impact efficacy or distribution.
